Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Ozempic TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: semaglutide
Brand name
(ARTG)
: OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled penDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:,- as monotherapy when metformin is not tolerated or contraindicated.,- in addition to other medicinal products for the treatment of type 2 diabetes.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Subcutaneous
- Clear and colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 pre-filled pen pack
- 1 pre-filled pen with disposable needles pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient semaglutide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Need more information?
These trusted information partners have more on this topic.
Top results
Ozempic Explained - myDr.com.au
It's the so-called weight loss wonder drug taking TikTok by storm and in the midst of a worldwide shortage. But what exactly is Ozempic, and is it right for you?
Read more on MyDoctor website
Can you overdose on Ozempic? - myDr.com.au
Ozempic is the weight loss drug everyone is talking about, but is it possible to have too much of a good thing? Here's what you should know
Read more on MyDoctor website
About the Ozempic (semaglutide) shortage 2022 - 2024 | Therapeutic Goods Administration (TGA)
Check this page for key information and updates on the Ozempic shortage.
Read more on TGA – Therapeutic Goods Administration website
Update: Prescribers advised not to start new patients on Ozempic | Therapeutic Goods Administration (TGA)
Read advice about not prescribing Ozempic to new patients unless there are no suitable alternatives or there is a compelling clinical reason.
Read more on TGA – Therapeutic Goods Administration website
Counterfeit semaglutide vials | Therapeutic Goods Administration (TGA)
The TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
Read more on TGA – Therapeutic Goods Administration website
Counterfeit Ozempic pens detected and adverse event reported | Therapeutic Goods Administration (TGA)
Consumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.
Read more on TGA – Therapeutic Goods Administration website
Wegovy to be available in Australia | Diabetes Australia
A new weight loss medicine, Wegovy, will be available in Australia from early August 2024.
Read more on Diabetes Australia website
Substandard semaglutide vials | Therapeutic Goods Administration (TGA)
The product tested is not listed in the ARTG and has not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation.
Read more on TGA – Therapeutic Goods Administration website
About the shortage of Ordine (morphine) oral liquid | Therapeutic Goods Administration (TGA)
Find out about the shortage of Ordine (morphine) oral liquid.
Read more on TGA – Therapeutic Goods Administration website
Diabetes medicines | Diabetes Australia
There are a range of glucose-lowering medications available to help you manage your diabetes. Consult your diabetes health team before any changes. Read more
Read more on Diabetes Australia website
Top results
Update: Prescribers advised not to start new patients on Ozempic | Therapeutic Goods Administration (TGA)
Read advice about not prescribing Ozempic to new patients unless there are no suitable alternatives or there is a compelling clinical reason.
Read more on TGA – Therapeutic Goods Administration website
Counterfeit Ozempic pens detected and adverse event reported | Therapeutic Goods Administration (TGA)
Consumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.
Read more on TGA – Therapeutic Goods Administration website
Substandard semaglutide vials | Therapeutic Goods Administration (TGA)
The product tested is not listed in the ARTG and has not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation.
Read more on TGA – Therapeutic Goods Administration website